Option Care Health (OPCH) risk factors, FY2024 10-K

Other

1. 01Company-Specific Risk Factors
2. 02Our revenue and profitability will decline if the pharmaceutical industry undergoes certain changes, including limiting or discontinuing research, development, production and marketing of the pharmaceuticals that are compatible with the services we provide
3. 03If we lose relationships with managed care organizations (“MCOs”) and other non-governmental third-party payers, we could lose access to a significant number of patients and our revenue and profitability could decline
4. 04The healthcare industry is highly competitive
5. 05If we are unable to maintain relationships with existing patient referral sources, our business and consolidated financial condition, results of operations, and cash flows could be materially adversely affected
6. 06Changes in industry pricing benchmarks could adversely affect our financial performance
7. 07Changes in our relationships with pharmaceutical suppliers, including changes in drug availability or pricing, could adversely affect our business and financial results
8. 08A disruption in pharmaceutical and medical supply could adversely impact our business
9. 09A shortage of qualified registered nursing staff, pharmacists and other professionals could adversely affect our ability to attract, train and retain qualified personnel and could increase operating costs
10. 10Introduction of new drugs, accelerated adoption of existing lower margin drugs or withdrawal of existing drugs could adversely affect our revenues and profitability when prescribers prescribe these drugs for their patients or they are mandated by Third-Party Payers
11. 11Failure to develop new services or adapt to changes and trends within the healthcare industry may adversely affect our business
12. 12Changes in future business conditions could cause business investments and/or recorded goodwill to become impaired, and our financial condition and results of operations could suffer if there is an impairment of goodwill
13. 13A significant change in, or noncompliance with, governmental regulations and other legal requirements could have a material adverse effect on our reputation and profitability
14. 14Federal actions and legislation may reduce reimbursement rates from governmental payers and adversely affect our results of operations
15. 15Delays in reimbursement may adversely affect our liquidity, cash flows and results of operations
16. 16We are subject to pricing pressures and other risks involved with Third-Party Payers
17. 17We face periodic reviews and billing audits by governmental and private payers, which could result in adverse findings that may negatively impact our business
18. 18If any of our pharmacies fail to comply with the conditions of participation in the Medicare program, that pharmacy could be terminated from Medicare, which could adversely affect our consolidated financial statements
19. 19We cannot predict the impact of changing requirements on compounding pharmacies

Risks Relating to Our Indebtedness

1. 20Our existing indebtedness could adversely affect our business and growth prospects
2. 21Despite our indebtedness, we may still incur significantly more debt, which could exacerbate the risks associated with our substantial leverage
3. 22We may not be able to generate sufficient cash flow to service all of our indebtedness and may be forced to take other actions to satisfy our obligations under such indebtedness, which may not be successful

Risks Relating to Our Common Stock

1. 23Provisions of our corporate governance documents could make an acquisition of us more difficult and may prevent attempts by our stockholders to replace or remove our current management, even if it is beneficial to our stockholders
2. 24Our third amended and restated certificate of incorporation designates the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us
3. 25We may issue shares of preferred stock in the future, which could make it difficult for another company to acquire us or could otherwise adversely affect holders of our common stock, which could depress the price of our common stock
4. 26We cannot guarantee that our stock repurchase program will be fully implemented or that it will enhance long-term stockholder value
5. 27Pending and future litigation could subject us to significant monetary damages and/or require us to change our business practices
6. 28We may be subject to liability claims for damages and other expenses that are not covered by insurance
7. 29Pressures relating to downturns in the economy could adversely affect our business and consolidated financial statements
8. 30Acquisitions, strategic investments and strategic relationships involve certain risks
9. 31Our business depends on our information systems. A cyber-attack, security breach or our inability to effectively integrate, manage and keep our information systems secure and operational could disrupt our operations
10. 32Our business is dependent on the services provided by third-party information technology vendors
11. 33We use, and may continue to expand our use of, machine learning and artificial intelligence (“AI”) technologies to deliver our services and operate our business
12. 34Failure to maintain effective internal control over our financial reporting could have an adverse effect on our ability to report our financial results on a timely and accurate basis
13. 35Acts of God, such as major weather disturbances, could disrupt our business